Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).
Sanofi hands out community health equity grants in ongoing effort to build trust with marginalized groups
Sanofi launched its “A Million Conversations” initiative last year with the goal to bridge the trust gap between the healthcare industry and marginalized communities. But
November 16, 2023